
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The dual role of neutrophils in cancer
Merav E. Shaul, Zvi G. Fridlender
Seminars in Immunology (2021) Vol. 57, pp. 101582-101582
Closed Access | Times Cited: 37
Merav E. Shaul, Zvi G. Fridlender
Seminars in Immunology (2021) Vol. 57, pp. 101582-101582
Closed Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1343
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1343
Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
Yuqing Ren, Ruizhi Wang, Siyuan Weng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Yuqing Ren, Ruizhi Wang, Siyuan Weng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Engineering and Targeting Neutrophils for Cancer Therapy
Jiahui Zhang, Jianmei Gu, Xu Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 24
Jiahui Zhang, Jianmei Gu, Xu Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 24
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
Heidi Braumüller, Bernhard Mauerer, J.C. Andri�s, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 39
Heidi Braumüller, Bernhard Mauerer, J.C. Andri�s, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 39
Tumor-activated neutrophils promote metastasis in breast cancer via the G-CSF-RLN2-MMP-9 axis
Youjing Sheng, Weidong Peng, Yan Huang, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 4, pp. 383-399
Open Access | Times Cited: 21
Youjing Sheng, Weidong Peng, Yan Huang, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 4, pp. 383-399
Open Access | Times Cited: 21
Neutrophil Nanodecoys Inhibit Tumor Metastasis by Blocking the Interaction between Tumor Cells and Neutrophils
Weiya Zeng, Yanru Wang, Qing Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 10, pp. 7363-7378
Closed Access | Times Cited: 11
Weiya Zeng, Yanru Wang, Qing Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 10, pp. 7363-7378
Closed Access | Times Cited: 11
Defining myeloid-derived suppressor cells
Leila Akkari, Ido Amit, Vincenzo Bronte, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 850-857
Closed Access | Times Cited: 7
Leila Akkari, Ido Amit, Vincenzo Bronte, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 850-857
Closed Access | Times Cited: 7
Neutrophils as immune effector cells in antibody therapy in cancer
Leonie M. Behrens, Marjolein van Egmond, Timo K. van den Berg
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 280-301
Open Access | Times Cited: 28
Leonie M. Behrens, Marjolein van Egmond, Timo K. van den Berg
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 280-301
Open Access | Times Cited: 28
The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
Chengyuan Li, Yucheng Xue, Eloy Yinwang, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
Chengyuan Li, Yucheng Xue, Eloy Yinwang, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia
Fangmin Zhong, Fangyi Yao, Zi-Hao Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Fangmin Zhong, Fangyi Yao, Zi-Hao Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
Y Pan, Yue Ma, Guanghai Dai
Nutrients (2023) Vol. 15, Iss. 19, pp. 4290-4290
Open Access | Times Cited: 12
Y Pan, Yue Ma, Guanghai Dai
Nutrients (2023) Vol. 15, Iss. 19, pp. 4290-4290
Open Access | Times Cited: 12
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
Leonie M. Behrens, Timo K. van den Berg, Marjolein van Egmond
Cancers (2022) Vol. 14, Iss. 14, pp. 3366-3366
Open Access | Times Cited: 21
Leonie M. Behrens, Timo K. van den Berg, Marjolein van Egmond
Cancers (2022) Vol. 14, Iss. 14, pp. 3366-3366
Open Access | Times Cited: 21
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection
Yun Hu, Sébastien Paris, Narayan Sahoo, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 11
Yun Hu, Sébastien Paris, Narayan Sahoo, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 11
Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment
Mathumathi Krishnamohan, Irena Kaplanov, Sapir Maudi-Boker, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3950-3950
Open Access | Times Cited: 3
Mathumathi Krishnamohan, Irena Kaplanov, Sapir Maudi-Boker, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3950-3950
Open Access | Times Cited: 3
Overcoming EGFR-TKI resistance by targeting the tumor microenvironment
Jinsong Zhang, Natalie I. Vokes, Man Li, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 3, pp. 151-161
Open Access | Times Cited: 3
Jinsong Zhang, Natalie I. Vokes, Man Li, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 3, pp. 151-161
Open Access | Times Cited: 3
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis
Georgia Lattanzi, Francesco Strati, Angélica Díaz‐Basabe, et al.
Mucosal Immunology (2023) Vol. 16, Iss. 3, pp. 326-340
Open Access | Times Cited: 9
Georgia Lattanzi, Francesco Strati, Angélica Díaz‐Basabe, et al.
Mucosal Immunology (2023) Vol. 16, Iss. 3, pp. 326-340
Open Access | Times Cited: 9
Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion
Rafał Staros, Agata Michalak, Kinga Rusinek, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3126-3126
Open Access | Times Cited: 14
Rafał Staros, Agata Michalak, Kinga Rusinek, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3126-3126
Open Access | Times Cited: 14
Targeted nanoparticles modify neutrophil function in vivo
Sandra Völs, Naomi Kaisar-Iluz, Merav E. Shaul, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Sandra Völs, Naomi Kaisar-Iluz, Merav E. Shaul, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment
Nannan Zhang, Junyu Zhou, Shun Li, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2
Nannan Zhang, Junyu Zhou, Shun Li, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2
Targeting NETosis: nature’s alarm system in cancer progression
Yixia Liang, Guo Wu, Jiabao Tan, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 2
Yixia Liang, Guo Wu, Jiabao Tan, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 2
CTC-neutrophil interaction: A key driver and therapeutic target of cancer metastasis
Chengyi Hu, Ling Long, Jie Lou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117474-117474
Open Access | Times Cited: 2
Chengyi Hu, Ling Long, Jie Lou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117474-117474
Open Access | Times Cited: 2
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Stephen J. Ralph, Maxwell Reynolds
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 527-542
Open Access | Times Cited: 13
Stephen J. Ralph, Maxwell Reynolds
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 527-542
Open Access | Times Cited: 13
Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
Jensen Abascal, Michael S. Oh, Elvira L. Liclican, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2404-2404
Open Access | Times Cited: 6
Jensen Abascal, Michael S. Oh, Elvira L. Liclican, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2404-2404
Open Access | Times Cited: 6
Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions
Sumedha Roy, Karen Fitzgerald, Almin Lalani, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 5
Sumedha Roy, Karen Fitzgerald, Almin Lalani, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 5